- Home
- CBRE vs COO Comparison
CBRE vs COO Comparison
Compare CBRE & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRE
- COO
- Stock Information
- Founded
- CBRE 1906
- COO 1980
- Country
- CBRE United States
- COO United States
- Employees
- CBRE N/A
- COO N/A
- Industry
- CBRE Real Estate
- COO Ophthalmic Goods
- Sector
- CBRE Finance
- COO Health Care
- Exchange
- CBRE Nasdaq
- COO Nasdaq
- Market Cap
- CBRE 46.5B
- COO 14.2B
- IPO Year
- CBRE 2004
- COO N/A
- Fundamental
- Price
- CBRE $163.49
- COO $73.50
- Analyst Decision
- CBRE Buy
- COO Buy
- Analyst Count
- CBRE 9
- COO 11
- Target Price
- CBRE $171.89
- COO $79.27
- AVG Volume (30 Days)
- CBRE 1.5M
- COO 2.6M
- Earning Date
- CBRE 10-23-2025
- COO 12-04-2025
- Dividend Yield
- CBRE N/A
- COO N/A
- EPS Growth
- CBRE 30.63
- COO 13.33
- EPS
- CBRE 4.05
- COO 2.04
- Revenue
- CBRE $39,325,000,000.00
- COO $4,045,700,000.00
- Revenue This Year
- CBRE $14.85
- COO $6.02
- Revenue Next Year
- CBRE $9.74
- COO $5.76
- P/E Ratio
- CBRE $40.19
- COO $36.04
- Revenue Growth
- CBRE 14.61
- COO 6.35
- 52 Week Low
- CBRE $108.45
- COO $61.78
- 52 Week High
- CBRE $171.00
- COO $109.04
- Technical
- Relative Strength Index (RSI)
- CBRE 62.37
- COO 58.63
- Support Level
- CBRE $150.12
- COO $68.49
- Resistance Level
- CBRE $171.00
- COO $76.23
- Average True Range (ATR)
- CBRE 3.50
- COO 2.03
- MACD
- CBRE 1.21
- COO 0.49
- Stochastic Oscillator
- CBRE 64.14
- COO 67.54
About CBRE CBRE Group Inc
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.